← All trials
NCT04750603
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2018
- Primary completion
- Jan 31, 2020
- Completion date
- Apr 15, 2020
- First posted
- Feb 11, 2021
- Last posted
- Feb 11, 2021
- Enrollment
- 92
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Technion UniversityLead sponsor
- Technion UniversityReponsible party - principal investigator
- Technion UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.